McCormick & Co MD | 8-K: FY2025 Q3 Revenue: USD 1.725 B

Revenue: As of FY2025 Q3, the actual value is USD 1.725 B.

EPS: As of FY2025 Q3, the actual value is USD 0.84.

EBIT: As of FY2025 Q3, the actual value is USD 338.9 M.

Financial Metrics by Segment

Segment Revenue

• Total Net Sales: Increased by 3% in the third quarter, including a 1% favorable impact from currency. Organic sales growth was 2%, driven by volume.
• Consumer Segment: Net sales increased by 4% to $973 million, including a 1% favorable impact from currency. Organic sales increased by 3%, driven by volume and product mix.
• Flavor Solutions Segment: Net sales increased by 1% to $752 million, with minimal impact from currency. Organic sales increased by 1%, driven by price.

Operational Metrics

• Gross Profit: Decreased by $5 million to $645.1 million from the comparable period in 2024. Gross profit margin contracted by 130 basis points to 37.4%.
• Adjusted Gross Profit: $646.1 million, with a margin contraction of 120 basis points to 37.5%.
• Operating Income: $288.7 million, a 0.8% increase from the year-ago period. Adjusted operating income was $293.6 million, a 1.8% increase.
• Net Income: $225.5 million, a 1.1% increase from the year-ago period. Adjusted net income was $229.1 million, a 2.1% increase.
• Earnings per Share (EPS): $0.84, compared to $0.83 in the year-ago period. Adjusted EPS was $0.85, compared to $0.83 in the year-ago period.

Cash Flow

• Operating Cash Flow: $420.2 million for the nine months ended August 31, 2025, compared to $463.2 million in the same period in 2024.
• Free Cash Flow: Not explicitly mentioned in the reference.

Unique Metrics

• Impact of Special Charges: Special charges lowered EPS by $0.01 per share in the third quarter of 2025. Adjusted EPS excluding special charges was $0.85.

Outlook / Guidance

• Net Sales Growth: Expected to be 0% to 2% as reported, and 1% to 3% in constant currency.
• Operating Income: Expected to grow by 1% to 3% as reported, and 2% to 4% in constant currency. Adjusted operating income is expected to grow by 2% to 4% as reported, and 3% to 5% in constant currency.
• Earnings per Share (EPS): Expected to be $2.95 to $3.00, with adjusted EPS expected to be $3.00 to $3.05.